NeuroPace (NPCE) Operating Expenses (2020 - 2026)

NeuroPace's Operating Expenses history runs 7 years deep, the most recent figure standing at $23.6 million for Q1 2026.

• On a quarterly basis, Operating Expenses rose 5.01% year-over-year to $23.6 million in Q1 2026; TTM through Mar 2026 was $94.7 million, a 14.97% increase from a year earlier, with the FY2025 full-year figure at $93.6 million, up 15.85% from the prior year.
• Operating Expenses grew to $23.6 million in Q1 2026 per NPCE's latest filing, from $22.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $25.0 million in Q2 2025 and bottomed at $18.0 million in Q1 2022.
• The 5-year median for Operating Expenses is $19.8 million (2023), against an average of $20.4 million.
• Across the five-year window, Operating Expenses jumped 45.72% in 2022 and retreated 0.35% in 2023, its largest moves.
• Year by year, Operating Expenses stood at $18.7 million in 2022, then fell by 0.35% to $18.6 million in 2023, then rose by 6.69% to $19.8 million in 2024, then rose by 12.62% to $22.3 million in 2025, then climbed by 5.69% to $23.6 million in 2026.
• Per Business Quant, the three latest NPCE Operating Expenses figures stand at $23.6 million (Q1 2026), $22.3 million (Q4 2025), and $23.8 million (Q3 2025).